Zhejiang Medicine Co., Ltd.

SHSE:600216 Stock Report

Market Cap: CN¥14.4b

Zhejiang Medicine Future Growth

Future criteria checks 3/6

Zhejiang Medicine is forecast to grow earnings and revenue by 27% and 10.9% per annum respectively. EPS is expected to grow by 26.8% per annum. Return on equity is forecast to be 9.8% in 3 years.

Key information

27.0%

Earnings growth rate

26.8%

EPS growth rate

Pharmaceuticals earnings growth19.4%
Revenue growth rate10.9%
Future return on equity9.8%
Analyst coverage

Low

Last updated23 Aug 2024

Recent future growth updates

Recent updates

Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

Sep 14
Is Zhejiang Medicine (SHSE:600216) A Risky Investment?

What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You

Aug 06
What Zhejiang Medicine Co., Ltd.'s (SHSE:600216) 27% Share Price Gain Is Not Telling You

Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15

Jul 05
Zhejiang Medicine (SHSE:600216) Is Reducing Its Dividend To CN¥0.15

The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet

Jun 21
The Market Doesn't Like What It Sees From Zhejiang Medicine Co., Ltd.'s (SHSE:600216) Earnings Yet

Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem

May 02
Zhejiang Medicine's (SHSE:600216) Earnings Are Weaker Than They Seem

Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet

Mar 29
Zhejiang Medicine (SHSE:600216) Has A Somewhat Strained Balance Sheet

Earnings and Revenue Growth Forecasts

SHSE:600216 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202611,0521,203N/A8582
12/31/202510,1651,114N/A1,8493
12/31/20249,3791,028N/A8793
6/30/20248,262473-66591N/A
3/31/20248,035426-109638N/A
12/31/20237,794430-163634N/A
9/30/20237,868356-127790N/A
6/30/20237,936421-121781N/A
3/31/20237,940393-134718N/A
12/31/20228,116540-455521N/A
9/30/20228,441779-115825N/A
6/30/20228,629928-320670N/A
3/31/20228,9131,039-186919N/A
12/31/20219,1291,0451971,137N/A
9/30/20218,709847105965N/A
6/30/20218,4167984021,209N/A
3/31/20218,1278365221,123N/A
12/31/20207,3277177211,257N/A
9/30/20207,154603201853N/A
6/30/20206,987489234782N/A
3/31/20206,92535867657N/A
12/31/20197,044343-126447N/A
9/30/20197,073210116496N/A
6/30/20197,052177111555N/A
3/31/20196,65532288693N/A
12/31/20186,859365141580N/A
9/30/20186,879636225652N/A
6/30/20186,60063255504N/A
3/31/20186,426694N/A335N/A
12/31/20175,693253N/A503N/A
9/30/20175,224176N/A375N/A
6/30/20175,122348N/A455N/A
3/31/20175,159409N/A535N/A
12/31/20165,279450N/A336N/A
9/30/20165,089378N/A381N/A
6/30/20164,994219N/A210N/A
3/31/20164,757255N/A17N/A
12/31/20154,497162N/A107N/A
9/30/20154,50562N/A253N/A
6/30/20154,43493N/A391N/A
3/31/20154,64447N/A475N/A
12/31/20144,832170N/A550N/A
9/30/20144,843326N/A595N/A
6/30/20144,860306N/A539N/A
3/31/20144,887365N/A597N/A
12/31/20134,933452N/A655N/A
9/30/20135,074550N/A622N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600216's forecast earnings growth (27% per year) is above the savings rate (2.9%).

Earnings vs Market: 600216's earnings (27% per year) are forecast to grow faster than the CN market (23.2% per year).

High Growth Earnings: 600216's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600216's revenue (10.9% per year) is forecast to grow slower than the CN market (13.3% per year).

High Growth Revenue: 600216's revenue (10.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600216's Return on Equity is forecast to be low in 3 years time (9.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y